Naung Latt Htun: High Clinical Suspicion in Acquired Hemophilia A is Essential
Naung Latt Htun, Internal Medicine Doctor at Ministry of Health Brunei Darussalam, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Excited to share that our latest case report has been published in Cureus Journal of Medical Science!
Acquired Hemophilia A (AHA) Associated With Malignancy and Antiphospholipid Antibodies: Two Case Reports With Distinct Etiologies
In this paper, we present two rare and clinically challenging cases of AHA – an uncommon but potentially life-threatening autoimmune bleeding disorder caused by factor VIII inhibitors.
Key highlights:
- AHA can present with unexplained bleeding and isolated prolonged aPTT
- Underlying causes can be diverse – including malignancy, autoimmune conditions, and infections
- Coexistence with antiphospholipid antibodies creates a complex paradox of bleeding vs thrombosis
- Early recognition and a dual management approach (bleeding control plus inhibitor eradication) are critical
These cases emphasize the importance of maintaining a high index of suspicion when evaluating unexplained bleeding, especially in patients with comorbid conditions.
Proud to have worked with an excellent team on this publication!”
Title: Acquired Hemophilia A (AHA) Associated With Malignancy and Antiphospholipid Antibodies: Two Case Reports With Distinct Etiologies
Authors: Naung Latt Htun, Hsan Theingi Win, Mohammad Abdullah, Hnin Kay Khine Oo, Dilip Thottacherry
Read the Full Article on Cureus Journal of Medical Science
Stay updated on all scientific advances with Hemostasis Today.
-
May 31, 2026, 13:16Caroline Kisia: Project ECHO Transforms Healthcare Around The World
-
May 31, 2026, 13:11Wolfgang Miesbach: From CD20 to CD38 – A New Dimension in ITTP Therapy
-
May 31, 2026, 13:05Ellia Tootoonchian: Advancing Equitable Care Through Global Collaboration at WFH 2026
-
May 31, 2026, 12:55Rishiraj Sinha: Transfusion Evidence Library Round-Up – International Thalassaemia Day 2026
-
May 31, 2026, 12:40Tareq Abadl: Key Differences Between Immune Thrombocytopenic Purpura and Thrombotic Thrombocytopenic Purpura
-
May 31, 2026, 12:37Jeyaraj Pandian: World Stroke Organization Advances Stroke Education and Care in Central Asia
-
May 31, 2026, 12:31Stephen James Ryan: We Validated the Norwegian Version of the Vision Impairment Screening Assessment in Stroke
-
May 31, 2026, 12:01Sheila Cristina Ouriques Martins: We Provide Practical, Real-World Examples on How to Implement Stroke Prevention Strategies
-
May 31, 2026, 11:51Seema Dawood: Principles of Blood Smear Examination and Interpretation